UBS Group AG

Holdings History for Apogee Therapeutics, Inc. - COMMON STOCK (APGE)

Symbol: APGE on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.01%	+0%	$73,579,866	974,826	+175,361	+22%	$75.48	Q4 2025
30 Sep 2025	0.01%	+0.01%	$31,762,745	799,465	+692,308	+646%	$39.73	Q3 2025
30 Jun 2025	0%	-0.01%	$4,653,829	107,157	-594,752	-85%	$43.43	Q2 2025
31 Mar 2025	0.01%	+0%	$26,223,320	701,909	+160,623		$37.36	Q1 2025
31 Dec 2024	0.01%	+0%	$24,520,256	541,286	+489,466	+945%	$45.30	Q4 2024
30 Sep 2024	0%	+0%	$3,043,907	51,820	+1,330	+2.6%	$58.74	Q3 2024
30 Jun 2024	0%	-0%	$1,986,782	50,490	-25,541	-34%	$39.35	Q2 2024
31 Mar 2024	0%	+0%	$5,052,260	76,031	+76,031	NEW	$66.45	Q1 2024
31 Dec 2023		-0%	$0	0	-3,557	-100%	$65.81	Q4 2023
30 Sep 2023	0%	+0%	$75,764	3,557	+3,557	NEW	$21.30	Q3 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.